补体因子Ⅰ与年龄相关性黄斑变性发生研究进展被引量：4

Recent advance research progress on complement factor Ⅰ and age-related macular degeneration

下载PDF

导出

摘要年龄相关性黄斑变性（AMD）是引起发达国家老年人视力丧失的主要原因之一.随着中国人口老龄化的进展,AMD的发病率逐年升高,补体系统异常激活的炎症学说是目前研究较为深入的可能发病机制之一.补体因子Ⅰ（CFI）是补体系统中重要的抑制因子,抑制补体系统异常激活可能降低AMD的发生率.近来有大量关于CFI单核苷酸多态性（SNPs）与AMD发病相关性的研究,对CFI在AMD发病中的作用机制、CFI-SNPs与AMD发生的相关性研究最新进展进行总结. Age-related macular degeneration （AMD） is one of the most important diseases that cause vision loss among older patients in developed countries.As the progress of population aging in China,the incidence of AMD is increasing.The activation of the complement system plays an important role in AMD pathogenesis.Complement factor Ⅰ （CFI） is an important complement regulator.In recent years,there have been numerous studies about CFI single-nucleotide polymorphisms （SNPs） and AMD.The mechanism of CFI and the association between CFI polymorphisms and AMD were reviewed in the article.

作者王琴赵海生李立

机构地区重庆医科大学附属第二医院眼科

出处《中华实验眼科杂志》 CAS CSCD 北大核心 2015年第2期189-192,共4页 Chinese Journal Of Experimental Ophthalmology

关键词年龄相关性黄斑变性补体系统补体因子Ⅰ 单核苷酸多态性 Age-related macular degeneration Complement system Complement factor Ⅰ Singlenucleotide polymorphisms

分类号 R774.5 [医药卫生—眼科]

引文网络
相关文献

参考文献45

1Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies [ J]. Ophthalmic Epidemio1,2004,11 ( 2 ) : 67 - 149. doi: 10. 1076/opep. 11.2.67.28158.
2Rein DB, Wittenborn JS, Zhang X, et al. Forecasting age-related macular degeneration through the year 2050 : the potential impact of new treatments [ J]. Arch Ophthalmol, 2009,127 ( 4 ) : 533 - 540. doi: I0. 1001/archophthalmol. 2009.58.
3Yang K, Liang YB, Gao LQ, et al. Prevalence of age-related macular degeneration in a rural Chinese population :the Handan Eye Study[ J]. Ophthalmology,2011,118 (7) : 1395 - 1401. doi: 10. 1016/j. ophtha. 2010.12. 030.
4Ding X,Patel M, Chan CC. Molecular pathology of age-related maculardegeneration [ J ]. Prog Retin Eye Res, 2009,28 ( 1 ) : 1 -18. doi: 10. 1016/j. preteyeres. 2008.10. 001.
5Seddon JM, Sharma S, Adelman RA. Evaluation of the clinical age- related maculopathy staging system [ J ]. Ophthalmology,2006,113 (2) : 260-266. doi:10. 1016/j. ophtha. 2005.11. 001.
6Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maeulopathy grading system[J]. Ophthalmology, 1991, 98 (7) : 1128-1134. doi : 10. 1016/S0161-6420(91 ) 32186-9.
7Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maeulopathy and age-related maeular degeneration. The International ARM Epidemiological Study Group [ J ]. Surv Ophthalmol, 1995,39 (5) : 367-374. doi: 10. 1016/S0039-6257 (05) 80092-X.
8Smith W,Assink J, Klein R, et al. Risk factors for age-related macular degeneration : Pooled findings from three continents [ J]. Ophthalmology, 2001,108 ( 4 ) : 697 -704. doi : 10. 1016/S0161-6420 ( O0 ) 00580-7.
9Chakravarthy U,Wong TY, Fletcher A, et al. Clinical risk factors for age- related macular degeneration:a systematic review and recta-analysis [ J ]. BMC Ophthalmo1,2010,10 : 31-44. doi : 10. 1186/1471-2415-10-31.
10Patel M, Chan CC. Immunopathological aspects of age-related macular degeneration [ J ]. Semin Immunopathol, 2008,30 ( 2 ) : 97 - 110. doi : 10.1007/s00281-008-0112-9.

二级参考文献18

1Bird AC. The Bowman lecture: towards an understanding of age- related macular disease. Eye,2003,17:457-466.
2Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age- related macular degeneration in the United States. Arch Ophthalmol, 2004,122 : 564 -572.
3Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing eye study. Ophthalmology, 2006,113 : 1134-1144.
4SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol, 2007,125:671-679.
5Caekett P, Wong TY, Aung T, et al. Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay eye study. Am J Ophthalmol, 2008,146: 960- 967.
6Purushottam J, Puran SB, Nalini SB, et al. The role of complement system in ocular diseases including uveitis and macular degeneration. Molecular Immunol, 2007,44:3901-3908.
7Sivaprasad S, Chang NV. The complement system and age-relatedmacular degeneration. Eye, 2006,20:867-872.
8Klein R J, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science, 2005, 308: 385-389.
9Gold B, Merriam JE, Zemant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age- related macnlar degeneration. Nat Goner, 2006, 38: 458-462.
10Mailer JB, Fagcrncss JA, Reynolds RC, et al. Variation in complement factor 3 is associated with risk of age-related maeular degeneration. Nat Goner, 2007,39 : 1200-1201.